Antiguo Hospital Civil de Guadalajara Fray Antonio Alcalde Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2011
NCT01541904
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Eva Elizabet Camarena Pulido | OPD Hospital Civil de Guadalajara

Active Ingredients

Drugs in Phase 3 Trials (1)

vitamin d3 (1 trial)

Drugs in Phase 2 Trials (3)

polyethylene glycol (1 trial)

propantheline bromide (pro-banthine) (1 trial)

ticlopidine (ticlid) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Conjunctivitis (Phase 2)

Conjunctivitis, Allergic (Phase 2)

Diabetes, Gestational (Phase 3)

Diabetes Mellitus (Phase 3)

Dry Eye Syndromes (Phase 2)

Keratoconjunctivitis Sicca (Phase 2)

Pregnancy in Diabetics (Phase 3)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4